KalVista Pharmaceuticals, Inc. (KALV) Stock Price

Symbol and logo of brand kalvista.com (KALV)

KalVista Pharmaceuticals (KALV) focuses on therapies for rare blood pathologies, attracting leading scientists through a system of stock options and scientific drive. This price chart illustrates the asset's dynamics, with its current metric standing at 26.98. The effective delivery of specific medications ensures patient access to treatment. Meanwhile, patent protection and FDA status create a powerful barrier to entry for new market players.

Price Chart: kalvista.com (KALV) for 07/04/2022 - 06/21/2026

KalVista Pharmaceuticals Inc - analytical breakdowns and key metrics (KALV)

- stock value and consensus price forecast:
Fundamental valuation:kalvista.com
Signature product of KalVista Pharma

The price reflects the market consensus regarding the asset's value, capturing the daily capital revaluation by investors. This indicator measures current demand for shares, transforming fundamental expectations into a specific monetary equivalent. The price trajectory visualizes the market reaction to KalVista Pharmaceuticals (KALV) transitioning toward the commercialization of its drug for hereditary angioedema. This price action demonstrates that future revenues remain independent of macroeconomic factors. The final price level serves as an indicator of confidence in the business model rather than an absolute measure of the company's quality.

Analysis of competing companies

Stock Price ARGX|Price Chart BNTX (BioNTech Inc.)|Stock Price ABVX (Abivax S.A.)|ADMA: Share Price|Protagonist Corp - Stock Price|IMVT: Price Chart|KNSA: Stock Price|GRFS - Market Chart|Price Chart Adaptive Biotechnologies Corporation|Celldex - Quote Chart|Stock Price AUPH|BCRX (BioCryst) - Price Performance Chart|Stock Price VERA (veratx.com)|Stock Price Dianthus Therapeutics Inc DNTH|PHVS - Price Chart|Price Performance Chart ABCL (AbCellera Biologics Inc.)|tourmalinebio.com (TRML) - Price Chart|Stock Quotes Precigen, Inc.|PHAR (pharming.com) - Stock Price|Stock Price Nektar|Stock Price UPB|ZBIO (Zenas Biopharma, Inc.) - Price Performance Chart|Stock Price IMNM (immunome.com)|Market Chart gossamerbio.com (GOSS)|SEPN - Price Chart|Pieris Pharma (PVLA) - Stock Quotes|Savara Pharma (SVRA) - Price Chart|Stock Quotes Rigel Pharmaceuticals|Stock Quotes ANAB|Stock Price astriatx.com|Price Chart enGene Bio (ENGN)|RAPT Therapeutics, Inc. - Share Price|Stock Price JBIO (Aerovate Therapeutics)|Aclaris (ACRS) - Market Price|KYTX - Price Chart|Tiziana Life Sciences - Price|CABA: Stock Price|Market Price Ventyx Biosciences Inc. (VTYX)|THTX (theratech.com) - Stock Price|Stock Price Avalo Therapeutics Inc|Stock Price ELDN|Agenus Inc. - Share Price|Stock Price CLYM (Climb Bio)|Price Performance Chart ZURA|ATYR - Price Chart|ADAG (adagene.com) - Share Price|IMA: Stock Price|Stock Quotes Shattuck Therapeutics|Stock Quotes EQ|CNTB: Price Performance Chart|Stock Price IMUX|ATRA - Market Price|inflarx.de - Stock Quotes|Stock Price X4 Pharma XFOR|Adicet Bio - Stock Price|Price Performance Chart CELU (celularity.com)|INMB: Stock Price|BRNS - Market Chart|KZR (kezarlifesciences.com) - Stock Price|SAB Biotherapeutics - Quote Chart|Stock Quotes AKTX (akaritx.com)|ENLV: Quote Chart|Stock Price QTTB (Q32 Bio Corp)|GOVX - Stock Quotes|EDSA - Price Chart|IBIO - Stock Price|CARM (carismatx.com) - Stock Quotes|XTLB: Price|BOLT (Bolt Biotherapeutics, Inc.) - Stock Price|HCW Biologics Inc. (HCWB) - Market Chart|Price Chart Aptevo (APVO)|Stock Price aimimmuno.com (AIM)|Price Chart Aditxt ADTX|Stock Price GRI Bio Corp GRI|XRTX - Price Chart|HIND (ReShape Lifesciences) - Share Price|revbiosciences.com (REVB) - Price Chart|INDP - Market Chart|SCNI (Scinai Immunotherapeutics Ltd) - Stock Price|Stock Price calcimedica.com|Stock Price AFMD|Market Chart Allakos Inc|Stock Price HOOK (HOOKIPA Pharma Inc.)|IGMS (IGM Bio) - Quote Chart|ITOS - Price Chart|Quote Chart OCEA|TC Biopharm (TCBP) - Price Chart|Stock Quotes Third Harmonic Bio, Inc